AT
Acrivon Therapeutics, Inc. Common Stock
🇺🇸XNAS.ACRVUnited StatesHealthcare
$1.73USDdown -0.10 (-5.46%)ClosedDelayed9:21 AM
FzScore
betaAnalysis is in beta - data may have gaps.
40/ 100
- Poor0-34
- Weak35-49
- Fair50-64
- Strong65-79
- Excellent80-100
Calculated Jun 28, 2026 - Next rebalance Jul 5, 2026 - Coverage 100%
Category radar
How to read
Each axis is a scored category from 0 to 100; a larger footprint is better and an unscored axis collapses to the centre.